2002;22(23):8184C8198
2002;22(23):8184C8198. the treatment of cancer. The challenge is to identify the group of individuals where targeted tumors are not only refractory to TGF–induced tumor suppressor functions but also responsive to tumor advertising effects of TGF-. TGF- pathway inhibitors including small and large molecules have now came into medical tests. Preclinical studies with these inhibitors have … Read more